Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
Company pair · Health
VS

Abridge vs Alloy Therapeutics: Valuation, Funding, Trajectory

Health Both private US-headquartered No Canborsa market

This comparison puts Abridge next to Alloy Therapeutics within health on size, funding and trajectory.

On this pageSide by sideValuation marksWhat each disclosesVerdictFAQ
AbridgePRIVATE · US
VS
Last valuation$5.3B$1B
Basis Post-money Post-money
As ofApr 2026Apr 2026
Founded20182011
Employees≈200≈50
On CanborsaNo marketNo market
At a glance
$5.3B
AbridgePost-money, Series E extension · Apr 2026
$1B
Alloy TherapeuticsPost-money, Series E · Apr 2026
5.30×
GapBoth post-money, in the same month
0 of 2
On CanborsaNeither company has a market
VS
Head-to-head · field by field

Abridge vs Alloy Therapeutics — side by side

Field
AbridgePRIVATE · FOUNDED 2018
Alloy TherapeuticsPRIVATE · FOUNDED 2011
VS
Last valuation
$5.3B Post-money
$1B Post-money
Valuation date
1 Apr 2026
15 Apr 2026
Valuation basis
Post-money
Post-money
Latest round
Series E extension
Series E
Round size
$316M
$40M
Named investors
Andreessen Horowitz IVP Elad Gil Lightspeed Venture Partners
8VC JIC Venture Growth Investments Echo Capital Mubadala Capital
Founded
2018
2011
Employees (est.)
≈200
≈50
Sector & HQ
Healthcare technology and AI (AI-powered clinical documentation) · 🇺🇸 US
Biotech · 🇺🇸 US
Status & market
Private — no Canborsa market
Private — no Canborsa market
Valuation · both companies on one scale

Valuation marks

Each bar is the last disclosed mark — $5.3B for Abridge (post-money, Apr 2026) and $1B for Alloy Therapeutics (post-money, Apr 2026).

Abridge
$5.3BPost-money · Apr 2026
$1BPost-money · Apr 2026
ABRIDGE · $5.3B · APR 2026ALLOY THERAPEUTICS · $1B · APR 2026
Abridge vs Alloy Therapeutics · what each company discloses

What each company discloses, and what it leaves out

AbridgePRIVATEHealth · US · 2018
+Last disclosed mark $5.3B — post-money, Apr 2026.
+Founded 2018 .
+≈200 employees.
+Latest round: Series E extension, $316M raised, led by Andreessen Horowitz.
Alloy TherapeuticsPRIVATEHealth · US · 2011
+Last disclosed mark $1B — post-money, Apr 2026.
+Founded 2011 .
+≈50 employees.
+Latest round: Series E, $40M raised.
Verdict

Verdict

The $5.3B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$316M, led by Andreessen Horowitz in Apr 2026.
A dated print: it moves only when a newer round is announced.
The $1B tells you…
What an investor paid for newly issued shares — a primary round, priced post-money.
How much capital arrived with it:$40Min Apr 2026.
A dated print: it moves only when a newer round is announced.

Both marks are post-money, so 5.30× compares like with like. Both are private: there is no public quote and no Canborsa market on either name.

Frequently asked questions

Are Abridge and Alloy Therapeutics in the same sector?›

Abridge's sector is Healthcare technology and AI (AI-powered clinical documentation); Alloy Therapeutics' sector is Biotech.

What is Abridge's valuation versus Alloy Therapeutics'?›

Abridge is valued at $5.3B, and Alloy Therapeutics at $1B.

How much capital have Abridge and Alloy Therapeutics raised in total?›

Abridge has raised $1B in total; Alloy Therapeutics has raised $165M.

Is Abridge or Alloy Therapeutics a public company?›

Abridge's status is private; Alloy Therapeutics' status is private.

Same pillar · company pairs

Neighbouring pairs in this sector

Abridge vs Commurecompany pair · health›
$7Btop valuation1.3×gap
Neuralink vs Zocdoccompany pair · health›
$9Btop valuation5.0×gap
Abridge vs HeartFlowcompany pair · health›
$5.3Btop valuation3.4×gap
HistoSonics vs Zocdoccompany pair · health›
$2.2Btop valuation1.2×gap
Alloy Therapeutics vs Commurecompany pair · health›
$7Btop valuation7.0×gap
Calyxo vs Egenesiscompany pair · health›
$684.6Mtop valuation2.0×gap
HistoSonics vs Neuralinkcompany pair · health›
$9Btop valuation4.0×gap
Abridge vs HistoSonicscompany pair · health›
$5.3Btop valuation2.4×gap
Keep exploring
More pairs in Health
Abridge vs Innovaccercompare · versus›Calyxo vs Kriya Therapeuticscompare · versus›Abridge vs Neuralinkcompare · versus›Abridge vs Zocdoccompare · versus›All company comparisonsindex›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
SpaceX (SPCX)US equity · perp›Cerebras Systems (CBRS)US equity · perp›NVIDIA (NVDA)US equity · perp›Microsoft (MSFT)US equity · perp›All 86 marketsindex›
Company pair · Health

Trade 86 markets on Canborsa

Canborsa

Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.

Markets
Crypto perpetualsStock perpetualsGold & commoditiesIndex perpetualsAll markets ›
Companies
SpaceXOpenAIAnthropicStripeAll companies ›
Compare
Perp feesFunding ratesNo-KYC platformsCanborsa vs AvantisCanborsa vs OstiumAll comparisons ›
Learn
What is a perpetual?Funding rates explainedAirdrops & pointsAll guides ›
© Canborsa 2026TermsPrivacy